Table 1.
Characteristics of the population at baseline.
| Variable (% or ± SD) | PROOF cohort (n = 1011) |
|---|---|
| Age (y) | 65.6 (± 0.80) |
| Sex, females | 609 (60) |
| BMI (kg.m−2) | 25.3 ± 3.75 |
| BMI < 25 kg.m−2 | 517 (51) |
| 25 ≥ BMI < 30 kg/m−2 | 389 (39) |
| BMI ≥ 30 kg/m−2 | 105 (10) |
| Blood pressure (BP, min, max) | |
| Systolic BP, mmHg | 140 (130, 155) |
| Diastolic BP, mmHg | 90 (80, 93) |
| Cardiovascular risk factors | |
| None | 195 (19) |
| 1 | 359 (36) |
| 2 | 304 (30) |
| ≥3 | 153 (15) |
| Hypertension | 365 (36) |
| hypercholesterolemia | 381 (38) |
| Familial history | 110 (11) |
| Type 2 diabetes | 57 (6) |
| Smoking | |
| Current smoker | 80 (8) |
| Former smoker | 276 (28) |
| Non-smoker | 648 (64) |
| Drug therapy | |
| Antihypertensive drug | 223 (24) |
| Diuretics | 103 (11) |
| ACE or ARB | 92 (10) |
| Beta-blockers | 86 (9) |
| Calcium channel blockers | 69 (7) |
| Other antihypertensive drugs | 16 (2) |
| Physical activity (h/d) | |
| LPA | 5.8 (±1.1) |
| MVPA | 1.2 (±0.3) |
| Sedentary behavior | 6.6 (±2.3) |
| Biology | |
| Glycemia, g/l | 1.01 (±0.21) |
| LDL cholesterol, g/l | 1.54 (±0.32) |
| HDL cholesterol, g/l | 0.52 (±0.14) |
| Total cholesterol, g/l | 2.26 (±0.37) |
| Triglycerides, g/l | 1.29 (±0.60) |
| C-reactive protein, mg/l (min, max) | 2 (1.00, 3.90) |